首页> 外文期刊>Analytical and bioanalytical chemistry >High-performance liquid chromatographic determination of cocaine and benzoylecgonine by direct injection of human blood plasma sample into an alkyl-diol-silica ADS) precolumn
【24h】

High-performance liquid chromatographic determination of cocaine and benzoylecgonine by direct injection of human blood plasma sample into an alkyl-diol-silica ADS) precolumn

机译:通过将人血浆样品直接注入烷基二醇-硅胶ADS)色谱柱中的高效液相色谱法测定可卡因和苯甲酰芽子碱

获取原文
获取原文并翻译 | 示例
           

摘要

A column-switching high-performance liquid chromatographic method with UV detection for the determination of cocaine (COC) and benzoylecgonine (BZE) in human blood plasma samples is described. The method uses an alkyl-diol-silica ADS-C18 extraction precolumn. A 50-μL plasma sample was introduced to the ADS precolumn in order to separate the analytes from proteins and endogenous compounds. The fraction containing COC and BZE was back-flushed and transferred to an Alltech mixed-mode C_(18)/cation-exchange analytical column for final separation. The validation of the method revealed quantitative recoveries from 95.0 to 99.0% for COC at three different concentrations (0.5, 1.0 and 2.0 μg mL~(-1)), and from 96.0 to 99.0% for BZE at the same concentration levels with coefficients of variation <4.00% (n = 5). The detection limit signal to noise ratio (S/N)>3) was 0.03 μg mL~(-1) for all the compounds with an injection volume of 50 μL. However, it was possible to enhance the sensitivity further by injecting larger plasma volumes, up to 200 μL, at the same optimal conditions. The overlap of sample preparation, analysis and reconditioning of the extraction column, increase the overall sample throughput to 5 samples h~(-1). The developed method has been applied to human blood plasma samples from subjects suspected of cocaine abuse.
机译:描述了一种具有紫外检测功能的柱切换高效液相色谱法,用于测定人血浆样品中的可卡因(COC)和苯甲酰芽子碱(BZE)。该方法使用烷基二醇二氧化硅ADS-C18萃取预柱。将50μL血浆样品引入ADS预柱,以从蛋白质和内源性化合物中分离出分析物。将含有COC和BZE的馏分反吹并转移到Alltech混合模式C_(18)/阳离子交换分析柱中进行最终分离。方法的验证表明,在三个不同浓度(0.5、1.0和2.0μgmL〜(-1))下,COC的定量回收率为95.0%至99.0%,在相同浓度水平下,BZE的定量回收率为96.0%至99.0%,系数为变异<4.00%(n = 5)。所有进样量为50μL的化合物的检出限信噪比(S / N)> 3)为0.03μgmL〜(-1)。但是,在相同的最佳条件下,通过注入最大200μL的较大血浆体积,可以进一步提高灵敏度。样品制备,萃取柱的分析和再处理的重叠,使总样品通量增加到5个样品h〜(-1)。该开发的方法已应用于疑似可卡因滥用者的人体血浆样品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号